Two de novo variations identified by massively parallel sequencing in 13 Chinese families with children diagnosed with autism spectrum disorder.

Shi-Jun Li,Shan-Shan Yu,Hong-Yu Luo,Xin Li,Bin Rao,Yi Wang,Zhen-Zhen Li,Gang Liu,Li-Ping Zou,Ji-Shui Zhang,Chen Feng,Jing Liu,Jian-Wei Liu,Nan Hu,Xiao-Qiao Chen,Sheng-Yuan Yu,Ke Li,Mian-Wang He,Xin-Guang Yu,Jun Wang,Sheng-Li Guo,Zhi-Ye Chen,Lei Zhang,Lin Ma
DOI: https://doi.org/10.1016/j.cca.2018.01.025
IF: 6.314
2018-01-01
Clinica Chimica Acta
Abstract:Autism spectrum disorder (ASD) is a genetically heterogeneous neurodevelopmental disorder characterized by impairments in social interaction and communication, and by restricted and repetitive behaviors. The genetic architecture of ASD has been elucidated, including chromosomal rearrangements, de novo or inherited rare variants, and copy number variants. However, the genetic mechanism of Chinese families with ASD children is explored rarely. To identify genetic pathogenesis, we performed massively parallel sequencing on 13 Chinese ASD trio families, and found two de novo variations. The novel de novo splice alteration c.664 + 2T > G in the DEAF1 gene and the novel de novo missense mutation c.95 C > T in the AADAT gene associated with ASD may be important clues for exploring the etiology of this disorder.
What problem does this paper attempt to address?